Indications

• Breast Cancer (see Breast Cancer, [[Breast Cancer]])
• Renal Cell Carcinoma (see Renal Cancer, [[Renal Cancer]]): FDA-approved

---

Pharmacology

• Tyrosine Kinase Inhibitor

Metabolism

• xxxx

---

Administration

• xxxx

Dose Adjustment

• Hepatic:
• Renal:

---

Adverse Effects

Dermatologic Adverse Effects

• Chemotherapy-Induced Acral Erythema (Hand-Foot Syndrome, Palmar-Plantar Erythrodysesthesia) (see Chemotherapy-Induced Acral Erythema, [[Chemotherapy-Induced Acral Erythema]])

Other Adverse Effects

• xxx
• xxx
• xxx

---

References

• xxxx